Magnesium in PDB 8un3: Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Enzymatic activity of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
All present enzymatic activity of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One):
3.6.5.2;
Protein crystallography data
The structure of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One), PDB code: 8un3
was solved by
M.H.Ultsch,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
48.69 /
2.07
|
Space group
|
P 32
|
Cell size a, b, c (Å), α, β, γ (°)
|
69.217,
69.217,
166.92,
90,
90,
120
|
R / Rfree (%)
|
16.2 /
19.1
|
Other elements in 8un3:
The structure of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
(pdb code 8un3). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 5 binding sites of Magnesium where determined in the
Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One), PDB code: 8un3:
Jump to Magnesium binding site number:
1;
2;
3;
4;
5;
Magnesium binding site 1 out
of 5 in 8un3
Go back to
Magnesium Binding Sites List in 8un3
Magnesium binding site 1 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg204
b:39.1
occ:1.00
|
O
|
A:HOH332
|
2.0
|
39.9
|
1.0
|
OG
|
A:SER17
|
2.0
|
32.2
|
1.0
|
O
|
A:HOH348
|
2.1
|
40.7
|
1.0
|
O
|
A:HOH319
|
2.1
|
37.2
|
1.0
|
O2B
|
A:GDP202
|
2.3
|
34.2
|
1.0
|
CB
|
A:SER17
|
3.2
|
33.3
|
1.0
|
PB
|
A:GDP202
|
3.5
|
29.1
|
1.0
|
O1B
|
A:GDP202
|
3.6
|
31.9
|
1.0
|
O1A
|
A:GDP202
|
3.8
|
43.7
|
1.0
|
OD2
|
A:ASP57
|
3.9
|
36.4
|
1.0
|
N
|
A:SER17
|
3.9
|
33.9
|
1.0
|
CA
|
A:SER17
|
4.1
|
30.1
|
1.0
|
O
|
A:ASP33
|
4.1
|
37.9
|
1.0
|
CA
|
A:PRO34
|
4.3
|
38.1
|
1.0
|
OD1
|
A:ASP57
|
4.3
|
31.2
|
1.0
|
O
|
A:PRO34
|
4.3
|
39.9
|
1.0
|
O3A
|
A:GDP202
|
4.4
|
34.6
|
1.0
|
CG
|
A:ASP57
|
4.5
|
33.5
|
1.0
|
PA
|
A:GDP202
|
4.5
|
35.6
|
1.0
|
O
|
A:ILE36
|
4.5
|
35.7
|
1.0
|
CD2
|
A:TYR32
|
4.6
|
35.8
|
1.0
|
O2A
|
A:GDP202
|
4.6
|
28.3
|
1.0
|
O3B
|
A:GDP202
|
4.6
|
31.3
|
1.0
|
C
|
A:PRO34
|
4.6
|
38.4
|
1.0
|
CB
|
A:ALA59
|
4.6
|
36.6
|
1.0
|
O
|
A:THR58
|
4.8
|
31.3
|
1.0
|
C
|
A:ASP33
|
4.9
|
38.9
|
1.0
|
|
Magnesium binding site 2 out
of 5 in 8un3
Go back to
Magnesium Binding Sites List in 8un3
Magnesium binding site 2 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg203
b:33.7
occ:1.00
|
O
|
B:HOH305
|
2.0
|
33.3
|
1.0
|
O
|
B:HOH335
|
2.0
|
34.5
|
1.0
|
O
|
B:HOH302
|
2.1
|
33.3
|
1.0
|
O
|
B:HOH303
|
2.1
|
33.3
|
1.0
|
OG
|
B:SER17
|
2.1
|
34.8
|
1.0
|
O
|
B:ASP33
|
2.4
|
43.8
|
1.0
|
O2B
|
B:GDP202
|
2.9
|
38.2
|
1.0
|
CB
|
B:SER17
|
3.3
|
36.2
|
1.0
|
CD2
|
B:TYR32
|
3.4
|
40.6
|
1.0
|
C
|
B:ASP33
|
3.5
|
38.5
|
1.0
|
CA
|
B:PRO34
|
3.6
|
40.3
|
1.0
|
N
|
B:PRO34
|
4.0
|
37.0
|
1.0
|
CE2
|
B:TYR32
|
4.0
|
39.7
|
1.0
|
C
|
B:PRO34
|
4.0
|
40.8
|
1.0
|
PB
|
B:GDP202
|
4.1
|
31.9
|
1.0
|
O1A
|
B:GDP202
|
4.1
|
39.9
|
1.0
|
O1B
|
B:GDP202
|
4.1
|
42.9
|
1.0
|
O
|
B:PRO34
|
4.1
|
41.5
|
1.0
|
O
|
B:ILE36
|
4.2
|
30.8
|
1.0
|
OD2
|
B:ASP57
|
4.3
|
37.0
|
1.0
|
CG
|
B:TYR32
|
4.5
|
39.7
|
1.0
|
CA
|
B:SER17
|
4.6
|
29.9
|
1.0
|
O
|
B:TYR32
|
4.7
|
43.7
|
1.0
|
N
|
B:ASP33
|
4.7
|
42.2
|
1.0
|
CA
|
B:ASP33
|
4.7
|
40.1
|
1.0
|
C
|
B:TYR32
|
4.7
|
43.0
|
1.0
|
N
|
B:SER17
|
4.7
|
35.2
|
1.0
|
CB
|
B:TYR32
|
4.7
|
38.7
|
1.0
|
CB
|
B:ALA59
|
4.7
|
36.5
|
1.0
|
O
|
B:HOH314
|
4.8
|
40.7
|
1.0
|
N
|
B:THR35
|
4.8
|
36.3
|
1.0
|
CB
|
B:PRO34
|
4.8
|
48.8
|
1.0
|
PA
|
B:GDP202
|
4.9
|
35.8
|
1.0
|
O3A
|
B:GDP202
|
5.0
|
36.1
|
1.0
|
|
Magnesium binding site 3 out
of 5 in 8un3
Go back to
Magnesium Binding Sites List in 8un3
Magnesium binding site 3 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg204
b:37.6
occ:1.00
|
O
|
B:HOH337
|
2.1
|
36.4
|
1.0
|
O
|
B:HOH311
|
2.3
|
32.5
|
1.0
|
O
|
B:HOH343
|
2.3
|
36.8
|
1.0
|
OD1
|
B:ASN26
|
2.3
|
53.1
|
1.0
|
OD1
|
B:ASP153
|
2.4
|
42.2
|
1.0
|
O
|
B:LEU23
|
2.8
|
33.5
|
1.0
|
CG
|
B:ASP153
|
3.4
|
36.8
|
1.0
|
NZ
|
B:LYS42
|
3.5
|
37.1
|
1.0
|
CG
|
B:ASN26
|
3.6
|
43.6
|
1.0
|
C
|
B:LEU23
|
3.6
|
36.2
|
1.0
|
CA
|
B:LEU23
|
3.7
|
35.8
|
1.0
|
OD2
|
B:ASP153
|
3.8
|
42.9
|
1.0
|
O
|
B:GLN22
|
3.8
|
42.2
|
1.0
|
O
|
B:HOH348
|
4.1
|
39.6
|
1.0
|
CD1
|
B:LEU23
|
4.3
|
29.1
|
1.0
|
ND2
|
B:ASN26
|
4.3
|
44.5
|
1.0
|
CG
|
B:LEU23
|
4.5
|
28.6
|
1.0
|
CB
|
B:LEU23
|
4.6
|
32.7
|
1.0
|
CB
|
B:ASN26
|
4.7
|
43.4
|
1.0
|
C
|
B:GLN22
|
4.7
|
36.0
|
1.0
|
N
|
B:LEU23
|
4.7
|
33.6
|
1.0
|
CB
|
B:ASP153
|
4.8
|
34.8
|
1.0
|
CA
|
B:ASN26
|
4.8
|
41.1
|
1.0
|
N
|
B:ILE24
|
4.9
|
38.3
|
1.0
|
CE
|
B:LYS42
|
4.9
|
39.9
|
1.0
|
|
Magnesium binding site 4 out
of 5 in 8un3
Go back to
Magnesium Binding Sites List in 8un3
Magnesium binding site 4 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 4 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg204
b:34.4
occ:1.00
|
O
|
C:HOH336
|
2.0
|
33.5
|
1.0
|
OG
|
C:SER17
|
2.1
|
31.8
|
1.0
|
O
|
C:HOH340
|
2.1
|
34.1
|
1.0
|
O2B
|
C:GDP202
|
2.2
|
33.1
|
1.0
|
O
|
C:HOH345
|
2.3
|
39.6
|
1.0
|
CB
|
C:SER17
|
3.1
|
32.0
|
1.0
|
PB
|
C:GDP202
|
3.5
|
25.4
|
1.0
|
OD2
|
C:ASP57
|
3.8
|
36.4
|
1.0
|
O3B
|
C:GDP202
|
3.8
|
27.7
|
1.0
|
N
|
C:SER17
|
3.9
|
33.3
|
1.0
|
O2A
|
C:GDP202
|
3.9
|
42.2
|
1.0
|
CA
|
C:SER17
|
4.1
|
27.4
|
1.0
|
O
|
C:ASP33
|
4.2
|
41.2
|
1.0
|
OD1
|
C:ASP57
|
4.3
|
33.7
|
1.0
|
O3A
|
C:GDP202
|
4.4
|
36.7
|
1.0
|
CD2
|
C:TYR32
|
4.4
|
36.0
|
1.0
|
CG
|
C:ASP57
|
4.4
|
33.0
|
1.0
|
O
|
C:ILE36
|
4.5
|
34.1
|
1.0
|
O1B
|
C:GDP202
|
4.5
|
30.1
|
1.0
|
PA
|
C:GDP202
|
4.5
|
34.5
|
1.0
|
CA
|
C:PRO34
|
4.5
|
42.0
|
1.0
|
O
|
C:PRO34
|
4.6
|
42.8
|
1.0
|
O1A
|
C:GDP202
|
4.6
|
25.9
|
1.0
|
CB
|
C:ALA59
|
4.7
|
37.1
|
1.0
|
O
|
C:THR58
|
4.7
|
35.5
|
1.0
|
C
|
C:PRO34
|
4.9
|
41.8
|
1.0
|
CE2
|
C:TYR32
|
5.0
|
38.1
|
1.0
|
C
|
C:LYS16
|
5.0
|
24.5
|
1.0
|
|
Magnesium binding site 5 out
of 5 in 8un3
Go back to
Magnesium Binding Sites List in 8un3
Magnesium binding site 5 out
of 5 in the Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One)
Mono view
Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 5 of Kras-G13D-Gdp in Complex with CPD5 (1-((S)-10-(6-Amino-4-Methyl-3- (Trifluoromethyl)Pyridin-2-Yl)-11-Chloro-7-(((2S,4R)-4-Fluoro-1- Methylpyrrolidin-2-Yl)Methoxy)-3,4,13,13A-Tetrahydropyrazino[2',1':3, 4][1,4]Oxazepino[5,6,7-De]Quinazolin-2(1H)-Yl)Prop-2-En-1-One) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:Mg203
b:34.2
occ:1.00
|
O
|
D:HOH309
|
1.8
|
32.2
|
1.0
|
O
|
D:HOH320
|
1.9
|
33.4
|
1.0
|
O
|
D:HOH306
|
2.1
|
28.4
|
1.0
|
O
|
D:HOH302
|
2.1
|
38.5
|
1.0
|
OG
|
D:SER17
|
2.4
|
35.3
|
1.0
|
O
|
D:ASP33
|
2.6
|
41.4
|
1.0
|
O2B
|
D:GDP202
|
2.6
|
38.0
|
1.0
|
CB
|
D:SER17
|
3.3
|
32.6
|
1.0
|
C
|
D:ASP33
|
3.5
|
36.7
|
1.0
|
CA
|
D:PRO34
|
3.5
|
43.9
|
1.0
|
CD2
|
D:TYR32
|
3.6
|
36.4
|
1.0
|
PB
|
D:GDP202
|
3.9
|
34.1
|
1.0
|
N
|
D:PRO34
|
3.9
|
38.4
|
1.0
|
O3B
|
D:GDP202
|
4.0
|
36.9
|
1.0
|
C
|
D:PRO34
|
4.0
|
40.6
|
1.0
|
O2A
|
D:GDP202
|
4.0
|
31.4
|
1.0
|
O
|
D:PRO34
|
4.1
|
43.3
|
1.0
|
O
|
D:ILE36
|
4.2
|
33.4
|
1.0
|
OD2
|
D:ASP57
|
4.2
|
34.8
|
1.0
|
CE2
|
D:TYR32
|
4.2
|
38.1
|
1.0
|
CA
|
D:SER17
|
4.6
|
31.9
|
1.0
|
N
|
D:ASP33
|
4.7
|
38.5
|
1.0
|
CG
|
D:TYR32
|
4.7
|
38.8
|
1.0
|
N
|
D:SER17
|
4.7
|
32.8
|
1.0
|
CA
|
D:ASP33
|
4.7
|
41.1
|
1.0
|
CB
|
D:ALA59
|
4.7
|
35.8
|
1.0
|
C
|
D:TYR32
|
4.7
|
39.6
|
1.0
|
O
|
D:TYR32
|
4.8
|
39.1
|
1.0
|
CB
|
D:TYR32
|
4.8
|
40.6
|
1.0
|
CB
|
D:PRO34
|
4.8
|
50.7
|
1.0
|
O1B
|
D:GDP202
|
4.8
|
31.4
|
1.0
|
PA
|
D:GDP202
|
4.8
|
31.8
|
1.0
|
N
|
D:THR35
|
4.8
|
32.2
|
1.0
|
O3A
|
D:GDP202
|
4.9
|
38.3
|
1.0
|
O1A
|
D:GDP202
|
5.0
|
31.6
|
1.0
|
|
Reference:
C.Nilewski,
M.H.Ultsch.
N/A N/A.
Page generated: Fri Oct 4 21:23:25 2024
|